Summit RC+S DBS Implant for OCD for Obsessive-Compulsive Disorder
This trial is for people with a hard-to-control form of OCD. The goal is to find a more reliable system for treating OCD by studying how to best place electrodes in the brain to deliver electrical stimulation.
- Obsessive-Compulsive Disorder
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there any restrictions on who can participate in this research project?
"This clinical trial is admitting a maximum of three individuals aged between twenty-one and seventy, suffering from Obsessive Compulsive Disorder. Criteria for admission includes being male or female; having experienced OCD symptoms which cause significant distress and impairment to their life for at least five years; a minimum score of 28 on the Yale–Brown Obsessive Compulsive Scale (Y-BOCS); failed augmentation therapy with one of six antipsychotics; inadequate response to Cognitive Behavioral Therapy consisting 25 hours of Exposure Response Prevention provided by an expert therapist."
Is this medical study open to individuals aged 45 and above?
"The requirements for this clinical trial stipulate that patients must be between 21 and 70 years old. There are 23 studies specifically tailored towards minors while 67 are geared to elderly individuals."
Is there an open enrollment period for this clinical experiment?
"According to the information presented on clinicaltrials.gov, this medical study is not presently recruiting patients. Initially posted in October 2019 and last updated February 2022, there are 114 alternative trials enrolling individuals at present."